{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T02:33:23Z","timestamp":1791772403476,"version":"4.3.4"},"reference-count":82,"publisher":"Oxford University Press (OUP)","issue":"3","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"},{"start":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T00:00:00Z","timestamp":1639353600000},"content-version":"vor","delay-in-days":377,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["132013-RSG-18-010-01-CCG"],"award-info":[{"award-number":["132013-RSG-18-010-01-CCG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005979","name":"Lustgarten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA122596"],"award-info":[{"award-number":["R01CA122596"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA194593"],"award-info":[{"award-number":["R01CA194593"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"name":"National Institute of Aging","award":["PO1AG039355"],"award-info":[{"award-number":["PO1AG039355"]}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR079379"],"award-info":[{"award-number":["R01AR079379"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007114","name":"Ralph W. and Grace M. Showalter Research Trust Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007114","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Veterans Administration","award":["1I01-BX004177-01"],"award-info":[{"award-number":["1I01-BX004177-01"]}]},{"DOI":"10.13039\/100000048","name":"American Cancer Society","doi-asserted-by":"publisher","award":["132013\u2010RSG\u201018\u2010010\u201001\u2010CCG"],"award-info":[{"award-number":["132013\u2010RSG\u201018\u2010010\u201001\u2010CCG"]}],"id":[{"id":"10.13039\/100000048","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005979","name":"Lustgarten Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005979","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA122596"],"award-info":[{"award-number":["R01CA122596"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA194593"],"award-info":[{"award-number":["R01CA194593"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["R01AR079379"],"award-info":[{"award-number":["R01AR079379"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007114","name":"Ralph W. and Grace M. Showalter Research Trust Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007114","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["asbmr.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,1]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Tumor- and bone-derived soluble factors have been proposed to participate in the alterations of skeletal muscle size and function in cachexia. We previously showed that mice bearing ovarian cancer (OvCa) exhibit cachexia associated with marked bone loss, whereas bone-targeting agents, such as bisphosphonates, are able to preserve muscle mass in animals exposed to anticancer drugs. De-identified CT images and plasma samples from female patients affected with OvCa were used for body composition assessment and quantification of circulating cross-linked C-telopeptide type I (CTX-I) and receptor activator of NF-kB ligand (RANKL), respectively. Female mice bearing ES-2 tumors were used to characterize cancer- and RANKL-associated effects on muscle and bone. Murine C2C12 and human HSMM myotube cultures were used to determine the OvCa- and RANKL-dependent effects on myofiber size. To the extent of isolating new regulators of bone and muscle in cachexia, here we demonstrate that subjects affected with OvCa display evidence of cachexia and increased bone turnover. Similarly, mice carrying OvCa present high RANKL levels. By using in vitro and in vivo experimental models, we found that elevated circulating RANKL is sufficient to cause skeletal muscle atrophy and bone resorption, whereas bone preservation by means of antiresorptive and anti-RANKL treatments concurrently benefit muscle mass and function in cancer cachexia. Altogether, our data contribute to identifying RANKL as a novel therapeutic target for the treatment of musculoskeletal complications associated with RANKL-expressing non-metastatic cancers. \u00a9 2021 American Society for Bone and Mineral Research (ASBMR).<\/jats:p>\n                  <jats:p>Abstract<\/jats:p>\n                  <jats:p>RANKL directly impairs muscle mass and function in cancer cachexia.<\/jats:p>\n                  <jats:p>Tumor-derived factors, including RANKL, drive bone resorption in non-bone metastatic cancer.<\/jats:p>\n                  <jats:p>Blockade of RANKL and cancer-associated bone resorption results in improved muscle mass and function, even in the absence of bone metastases.<\/jats:p>\n                  <jats:p\/>","DOI":"10.1002\/jbmr.4480","type":"journal-article","created":{"date-parts":[[2021,12,13]],"date-time":"2021-12-13T23:36:32Z","timestamp":1639438592000},"page":"381-396","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["RANKL Blockade Reduces Cachexia and Bone Loss Induced by Non-Metastatic Ovarian Cancer in Mice"],"prefix":"10.1093","volume":"37","author":[{"given":"Fabrizio","family":"Pin","sequence":"first","affiliation":[{"name":"Department of Anatomy, Cell Biology and Physiology Indiana University School of Medicine Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9219-285X","authenticated-orcid":false,"given":"Alexander J","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology-Head & Neck Surgery Indiana University School of Medicine Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua R","family":"Huot","sequence":"additional","affiliation":[{"name":"Department of Surgery Indiana University School of Medicine Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok","family":"Narasimhan","sequence":"additional","affiliation":[{"name":"Department of Surgery Indiana University School of Medicine Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa A","family":"Zimmers","sequence":"additional","affiliation":[{"name":"Indiana Center for Musculoskeletal Health Indiana University School of Medicine Indianapolis IN USA"},{"name":"Simon Comprehensive Cancer Center Indiana University School of Medicine Indianapolis IN USA"},{"name":"Department of Surgery Indiana University School of Medicine Indianapolis IN USA"},{"name":"Department of Otolaryngology-Head & Neck Surgery Indiana University School of Medicine Indianapolis IN USA"},{"name":"Department of Anatomy, Cell Biology and Physiology Indiana University School of Medicine Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda F","family":"Bonewald","sequence":"additional","affiliation":[{"name":"Indiana Center for Musculoskeletal Health Indiana University School of Medicine Indianapolis IN USA"},{"name":"Simon Comprehensive Cancer Center Indiana University School of Medicine Indianapolis IN USA"},{"name":"Department of Anatomy, Cell Biology and Physiology Indiana University School of Medicine Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3235-1871","authenticated-orcid":false,"given":"Andrea","family":"Bonetto","sequence":"additional","affiliation":[{"name":"Indiana Center for Musculoskeletal Health Indiana University School of Medicine Indianapolis IN USA"},{"name":"Simon Comprehensive Cancer Center Indiana University School of Medicine Indianapolis IN USA"},{"name":"Department of Surgery Indiana University School of Medicine Indianapolis IN USA"},{"name":"Department of Otolaryngology-Head & Neck Surgery Indiana University School of Medicine Indianapolis IN USA"},{"name":"Department of Anatomy, Cell Biology and Physiology Indiana University School of Medicine Indianapolis IN USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2021,12,13]]},"reference":[{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0001","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3322\/caac.21590","article-title":"Cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA Cancer J Clin."},{"issue":"2","key":"2024012714033572800_jbmr4480-bib-0002","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1097\/IGC.0000000000000867","article-title":"Sarcopenia in advanced serous ovarian cancer","volume":"27","author":"Bronger","year":"2017","journal-title":"Int J Gynecol Cancer."},{"issue":"4B","key":"2024012714033572800_jbmr4480-bib-0003","first-page":"2941","article-title":"Malnutrition and cachexia in ovarian cancer patients: pathophysiology and management","volume":"21","author":"Gadducci","year":"2001","journal-title":"Anticancer Res."},{"issue":"2","key":"2024012714033572800_jbmr4480-bib-0004","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1002\/jcsm.12524","article-title":"Muscle loss during primary debulking surgery and chemotherapy predicts poor survival in advanced-stage ovarian cancer","volume":"11","author":"Huang","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10549-005-5991-z","article-title":"Objective and subjective upper body function six months following diagnosis of breast cancer","volume":"94","author":"Hayes","year":"2005","journal-title":"Breast Cancer Res Treat."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0006","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11136-007-9215-3","article-title":"Fatigue in breast cancer survivors two to five years post diagnosis: a HEAL Study report","volume":"16","author":"Meeske","year":"2007","journal-title":"Qual Life Res."},{"issue":"5","key":"2024012714033572800_jbmr4480-bib-0007","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S1470-2045(10)70218-7","article-title":"Definition and classification of cancer cachexia: an international consensus","volume":"12","author":"Fearon","year":"2011","journal-title":"Lancet Oncol."},{"issue":"5","key":"2024012714033572800_jbmr4480-bib-0008","doi-asserted-by":"crossref","first-page":"758","DOI":"10.4158\/EP12141.RA","article-title":"Bone as an endocrine organ","volume":"18","author":"Guntur","year":"2012","journal-title":"Endocr Pract."},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0009","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-organ crosstalk: the emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr Rev"},{"issue":"11","key":"2024012714033572800_jbmr4480-bib-0010","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1038\/nm.3961","article-title":"Excess TGF-beta mediates muscle weakness associated with bone metastases in mice","volume":"21","author":"Waning","year":"2015","journal-title":"Nat Med."},{"issue":"5","key":"2024012714033572800_jbmr4480-bib-0011","doi-asserted-by":"crossref","first-page":"8406","DOI":"10.18632\/oncotarget.14139","article-title":"Aromatase inhibitor-induced bone loss increases the progression of estrogen receptor-negative breast cancer in bone and exacerbates muscle weakness in vivo","volume":"8","author":"Wright","year":"2017","journal-title":"Oncotarget."},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0012","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/jcsm.12311","article-title":"Growth of ovarian cancer xenografts causes loss of muscle and bone mass: a new model for the study of cancer cachexia","volume":"9","author":"Pin","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle."},{"key":"2024012714033572800_jbmr4480-bib-0013","first-page":"679","article-title":"Differential bone loss in mouse models of colon cancer cachexia","volume":"7","author":"Bonetto","year":"2016","journal-title":"Front Physiol."},{"key":"2024012714033572800_jbmr4480-bib-0014","doi-asserted-by":"crossref","first-page":"809","DOI":"10.3389\/fendo.2019.00809","article-title":"Bisphosphonate treatment ameliorates chemotherapy-induced bone and muscle abnormalities in young mice","volume":"10","author":"Essex","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0015","doi-asserted-by":"crossref","first-page":"14470","DOI":"10.1038\/s41598-017-15040-1","article-title":"ACVR2B\/Fc counteracts chemotherapy-induced loss of muscle and bone mass","volume":"7","author":"Barreto","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"2024012714033572800_jbmr4480-bib-0016","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1084\/jem.188.5.997","article-title":"TRANCE is necessary and sufficient for osteoblast-mediated activation of bone resorption in osteoclasts","volume":"188","author":"Fuller","year":"1998","journal-title":"J Exp Med"},{"issue":"8","key":"2024012714033572800_jbmr4480-bib-0017","doi-asserted-by":"crossref","first-page":"C663","DOI":"10.1152\/ajpcell.00285.2015","article-title":"Muscle RANK is a key regulator of Ca2+ storage, SERCA activity, and function of fast-twitch skeletal muscles","volume":"310","author":"Dufresne","year":"2016","journal-title":"Am J Physiol Cell Physiol"},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0018","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3390\/cancers11060791","article-title":"Clinical impact of RANK signalling in ovarian cancer","volume":"11","author":"Wieser","year":"2019","journal-title":"Cancers"},{"issue":"7084","key":"2024012714033572800_jbmr4480-bib-0019","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nature04524","article-title":"Regulation of cancer cell migration and bone metastasis by RANKL","volume":"440","author":"Jones","year":"2006","journal-title":"Nature."},{"issue":"3","key":"2024012714033572800_jbmr4480-bib-0020","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jcp.22402","article-title":"Expression pattern of receptor activator of NFkappaB (RANK) in a series of primary solid tumors and related bone metastases","volume":"226","author":"Santini","year":"2011","journal-title":"J Cell Physiol."},{"issue":"3","key":"2024012714033572800_jbmr4480-bib-0021","doi-asserted-by":"crossref","first-page":"e6265","DOI":"10.1590\/1414-431x20176265","article-title":"Rankl expression predicts poor prognosis in gastric cancer patients: results from a retrospective and single-center analysis","volume":"51","author":"Zhang","year":"2018","journal-title":"Braz J Med Biol Res"},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0022","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.cytogfr.2004.06.004","article-title":"The molecular triad OPG\/RANK\/RANKL: involvement in the orchestration of pathophysiological bone remodeling","volume":"15","author":"Theoleyre","year":"2004","journal-title":"Cytokine Growth Factor Rev."},{"key":"2024012714033572800_jbmr4480-bib-0023","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1196\/annals.1443.016","article-title":"RANK\/RANKL: regulators of immune responses and bone physiology","volume":"1143","author":"Leibbrandt","year":"2008","journal-title":"Ann N Y Acad Sci."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0024","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4049\/jimmunol.1103387","article-title":"Crystal structure of human RANKL complexed with its decoy receptor osteoprotegerin","volume":"189","author":"Luan","year":"2012","journal-title":"J Immunol."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-018-0533-1","article-title":"Genetic deletion of muscle RANK or selective inhibition of RANKL is not as effective as full-length OPG-fc in mitigating muscular dystrophy","volume":"6","author":"Dufresne","year":"2018","journal-title":"Acta Neuropathol Commun"},{"issue":"18","key":"2024012714033572800_jbmr4480-bib-0026","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/ddz124","article-title":"An anti-RANKL treatment reduces muscle inflammation and dysfunction and strengthens bone in dystrophic mice","volume":"28","author":"Hamoudi","year":"2019","journal-title":"Hum Mol Genet"},{"issue":"8","key":"2024012714033572800_jbmr4480-bib-0027","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1172\/JCI125915","article-title":"RANKL inhibition improves muscle strength and insulin sensitivity and restores bone mass","volume":"129","author":"Bonnet","year":"2019","journal-title":"J Clin Invest."},{"issue":"8","key":"2024012714033572800_jbmr4480-bib-0028","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jbmr.4021","article-title":"TNF receptor-associated factor 6 mediates TNFalpha-induced skeletal muscle atrophy in mice during aging","volume":"35","author":"Li","year":"2020","journal-title":"J Bone Miner Res."},{"issue":"7","key":"2024012714033572800_jbmr4480-bib-0029","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1083\/jcb.201006098","article-title":"Targeted ablation of TRAF6 inhibits skeletal muscle wasting in mice","volume":"191","author":"Paul","year":"2010","journal-title":"J Cell Biol."},{"issue":"2","key":"2024012714033572800_jbmr4480-bib-0030","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3322\/caac.21388","article-title":"The eighth edition AJCC cancer staging manual: continuing to build a bridge from a population-based to a more \"personalized\" approach to cancer staging","volume":"67","author":"Amin","year":"2017","journal-title":"CA Cancer J Clin."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0031","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/00000421-198212000-00014","article-title":"Toxicity and response criteria of the Eastern Cooperative Oncology Group","volume":"5","author":"Oken","year":"1982","journal-title":"Am J Clin Oncol."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0032","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am J Clin Nutr."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0033","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.clnu.2008.06.013","article-title":"Cachexia: a new definition","volume":"27","author":"Evans","year":"2008","journal-title":"Clin Nutr."},{"issue":"2","key":"2024012714033572800_jbmr4480-bib-0034","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/IGC.0000000000001157","article-title":"Sarcopenia and skeletal muscle quality as predictors of postoperative complication and early mortality in gynecologic cancer","volume":"28","author":"Silva de Paula","year":"2018","journal-title":"Int J Gynecol Cancer"},{"key":"2024012714033572800_jbmr4480-bib-0035","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1038\/ncomms3126","article-title":"Evaluating cell lines as tumour models by comparison of genomic profiles","volume":"4","author":"Domcke","year":"2013","journal-title":"Nat Commun."},{"issue":"2","key":"2024012714033572800_jbmr4480-bib-0036","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2015.05.040","article-title":"In vivo tumor growth of high-grade serous ovarian cancer cell lines","volume":"138","author":"Mitra","year":"2015","journal-title":"Gynecol Oncol."},{"issue":"117","key":"2024012714033572800_jbmr4480-bib-0037","first-page":"54893","article-title":"The Colon-26 carcinoma tumor-bearing mouse as a model for the study of cancer cachexia","volume":"30","author":"Bonetto","year":"2016","journal-title":"J Vis Exp"},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0038","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1093\/carcin\/21.4.585","article-title":"Development of a syngeneic mouse model for events related to ovarian cancer","volume":"21","author":"Roby","year":"2000","journal-title":"Carcinogenesis."},{"issue":"11","key":"2024012714033572800_jbmr4480-bib-0039","first-page":"5379","article-title":"Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors","volume":"43","author":"Hamilton","year":"1983","journal-title":"Cancer Res."},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0040","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1096\/fj.13-245894","article-title":"Elevated expression of activins promotes muscle wasting and cachexia","volume":"28","author":"Chen","year":"2014","journal-title":"FASEB J."},{"issue":"3","key":"2024012714033572800_jbmr4480-bib-0041","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1016\/j.bbagen.2012.11.009","article-title":"Mitochondrial and sarcoplasmic reticulum abnormalities in cancer cachexia: altered energetic efficiency?","volume":"1830","author":"Fontes-Oliveira","year":"2013","journal-title":"Biochim Biophys Acta."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0042","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/jcsm.12642","article-title":"ACVR2B antagonism as a countermeasure to multi-organ perturbations in metastatic colorectal cancer cachexia","volume":"11","author":"Huot","year":"2020","journal-title":"J Cachexia Sarcopenia Muscle."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0043","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0044","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1093\/bioinformatics\/bts731","article-title":"NGSUtils: a software suite for analyzing and manipulating next-generation sequencing datasets","volume":"29","author":"Breese","year":"2013","journal-title":"Bioinformatics."},{"issue":"7","key":"2024012714033572800_jbmr4480-bib-0045","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"featureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics."},{"issue":"19","key":"2024012714033572800_jbmr4480-bib-0046","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1093\/bioinformatics\/btw354","article-title":"MultiQC: summarize analysis results for multiple tools and samples in a single report","volume":"32","author":"Ewels","year":"2016","journal-title":"Bioinformatics."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0047","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"edgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0048","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"2024012714033572800_jbmr4480-bib-0049","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1139\/H08-075","article-title":"A practical and precise approach to quantification of body composition in cancer patients using computed tomography images acquired during routine care","volume":"33","author":"Mourtzakis","year":"2008","journal-title":"Appl Physiol Nutr Metab."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0050","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.bone.2011.09.052","article-title":"Osteocyte apoptosis regulates osteoclast precursor adhesion via osteocytic IL-6 secretion and endothelial ICAM-1 expression","volume":"50","author":"Cheung","year":"2012","journal-title":"Bone."},{"key":"2024012714033572800_jbmr4480-bib-0051","doi-asserted-by":"crossref","first-page":"543","DOI":"10.3389\/fendo.2019.00543","article-title":"Molecular mechanisms responsible for the rescue effects of pamidronate on muscle atrophy in pediatric burn patients","volume":"10","author":"Pin","year":"2019","journal-title":"Front Endocrinol (Lausanne)."},{"issue":"9","key":"2024012714033572800_jbmr4480-bib-0052","doi-asserted-by":"crossref","first-page":"e136687","DOI":"10.1172\/jci.insight.136687","article-title":"Formation of colorectal liver metastases induces musculoskeletal and metabolic abnormalities consistent with exacerbated cachexia","volume":"5","author":"Huot","year":"2020","journal-title":"JCI Insight."},{"issue":"3","key":"2024012714033572800_jbmr4480-bib-0053","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ygyno.2013.03.003","article-title":"Nutritional status, CT body composition measures and survival in ovarian cancer","volume":"129","author":"Torres","year":"2013","journal-title":"Gynecol Oncol."},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0054","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1016\/j.ejso.2016.12.016","article-title":"The influence of sarcopenia on survival and surgical complications in ovarian cancer patients undergoing primary debulking surgery","volume":"43","author":"Rutten","year":"2017","journal-title":"Eur J Surg Oncol."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0055","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/S0022-5347(05)64985-3","article-title":"Changes in bone mineral density, lean body mass and fat content as measured by dual energy X-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy","volume":"167","author":"Berruti","year":"2002","journal-title":"J Urol."},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0056","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(99)00301-5","article-title":"Androgen deprivation therapy for prostate cancer results in significant loss of bone density","volume":"54","author":"Wei","year":"1999","journal-title":"Urology."},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0057","doi-asserted-by":"crossref","first-page":"470","DOI":"10.5468\/ogs.20012","article-title":"Effect of gynecological cancer and its treatment on bone mineral density and the risk of osteoporosis and osteoporotic fracture","volume":"63","author":"Lee","year":"2020","journal-title":"Obstet Gynecol Sci."},{"issue":"10","key":"2024012714033572800_jbmr4480-bib-0058","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/jjco\/hyf082","article-title":"Prospective study of decreased bone mineral density in patients with cervical cancer without bone metastases: a preliminary report","volume":"32","author":"Hung","year":"2002","journal-title":"Jpn J Clin Oncol."},{"issue":"25","key":"2024012714033572800_jbmr4480-bib-0059","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1056\/NEJM197512182932502","article-title":"Prostaglandins as mediators of hypercalcemia associated with certain types of cancer","volume":"293","author":"Seyberth","year":"1975","journal-title":"N Engl J Med"},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0060","first-page":"403","article-title":"High-molecular-weight transforming growth factor activity in the urine of patients with disseminated cancer","volume":"43","author":"Sherwin","year":"1983","journal-title":"Cancer Res."},{"issue":"4817","key":"2024012714033572800_jbmr4480-bib-0061","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1126\/science.3616618","article-title":"A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression","volume":"237","author":"Suva","year":"1987","journal-title":"Science"},{"issue":"3","key":"2024012714033572800_jbmr4480-bib-0062","doi-asserted-by":"crossref","first-page":"314","DOI":"10.5535\/arm.2019.43.3.314","article-title":"Single dose therapy of zoledronic acid for the treatment of transient osteoporosis of hip","volume":"43","author":"Agarwala","year":"2019","journal-title":"Ann Rehabil Med."},{"key":"2024012714033572800_jbmr4480-bib-0063","first-page":"CD003474","article-title":"Bisphosphonates and other bone agents for breast cancer","volume":"10","author":"O'Carrigan","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"2024012714033572800_jbmr4480-bib-0064","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.ctrv.2019.05.003","article-title":"Management of bone health in solid tumours: from bisphosphonates to a monoclonal antibody","volume":"76","author":"von Moos","year":"2019","journal-title":"Cancer Treat Rev."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0065","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1002\/jbmr.2162","article-title":"Pamidronate attenuates muscle loss after pediatric burn injury","volume":"29","author":"Borsheim","year":"2014","journal-title":"J Bone Miner Res."},{"key":"2024012714033572800_jbmr4480-bib-0066","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.canlet.2021.06.030","article-title":"Non-bone metastatic cancers promote osteocyte-induced bone destruction","volume":"520","author":"Pin","year":"2021","journal-title":"Cancer Lett."},{"issue":"31","key":"2024012714033572800_jbmr4480-bib-0067","doi-asserted-by":"crossref","first-page":"18934","DOI":"10.1074\/jbc.M115.642090","article-title":"Inhibition of osteocyte apoptosis prevents the increase in osteocytic receptor activator of nuclear factor kappaB ligand (RANKL) but does not stop bone resorption or the loss of bone induced by unloading","volume":"290","author":"Plotkin","year":"2015","journal-title":"J Biol Chem"},{"issue":"10","key":"2024012714033572800_jbmr4480-bib-0068","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J Clin Invest."},{"issue":"6","key":"2024012714033572800_jbmr4480-bib-0069","doi-asserted-by":"crossref","first-page":"e20190450","DOI":"10.1084\/jem.20190450","article-title":"Tumor-derived IL-6 and trans-signaling among tumor, fat, and muscle mediate pancreatic cancer cachexia","volume":"218","author":"Rupert","year":"2021","journal-title":"J Exp Med"},{"issue":"9","key":"2024012714033572800_jbmr4480-bib-0070","doi-asserted-by":"crossref","first-page":"e0138189","DOI":"10.1371\/journal.pone.0138189","article-title":"Osteocytes, not osteoblasts or lining cells, are the main source of the RANKL required for osteoclast formation in remodeling bone","volume":"10","author":"Xiong","year":"2015","journal-title":"PLoS One."},{"issue":"7","key":"2024012714033572800_jbmr4480-bib-0071","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1359\/jbmr.2000.15.7.1321","article-title":"Prostaglandin E2 induces expression of receptor activator of nuclear factor-kappa B ligand\/osteoprotegrin ligand on pre-B cells: implications for accelerated osteoclastogenesis in estrogen deficiency","volume":"15","author":"Kanematsu","year":"2000","journal-title":"J Bone Miner Res."},{"issue":"23","key":"2024012714033572800_jbmr4480-bib-0072","doi-asserted-by":"crossref","first-page":"20659","DOI":"10.1074\/jbc.M010153200","article-title":"Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis","volume":"276","author":"Collin-Osdoby","year":"2001","journal-title":"J Biol Chem."},{"issue":"4","key":"2024012714033572800_jbmr4480-bib-0073","doi-asserted-by":"crossref","first-page":"e00366","DOI":"10.1042\/BSR20160150","article-title":"RANK-RANKL signalling in cancer","volume":"36","author":"Renema","year":"2016","journal-title":"Biosci Rep"},{"issue":"3","key":"2024012714033572800_jbmr4480-bib-0074","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1093\/hmg\/ddz312","article-title":"Muscle weakness and selective muscle atrophy in osteoprotegerin-deficient mice","volume":"29","author":"Hamoudi","year":"2020","journal-title":"Hum Mol Genet."},{"issue":"5","key":"2024012714033572800_jbmr4480-bib-0075","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/jbmr.2112","article-title":"Novel genetic models of osteoporosis by overexpression of human RANKL in transgenic mice","volume":"29","author":"Rinotas","year":"2014","journal-title":"J Bone Miner Res."},{"issue":"2","key":"2024012714033572800_jbmr4480-bib-0076","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1359\/jbmr.081112","article-title":"Denosumab, a fully human monoclonal antibody to RANKL, inhibits bone resorption and increases BMD in knock-in mice that express chimeric (murine\/human) RANKL","volume":"24","author":"Kostenuik","year":"2009","journal-title":"J Bone Miner Res."},{"key":"2024012714033572800_jbmr4480-bib-0077","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3389\/fcell.2020.00325","article-title":"Pros and cons of denosumab treatment for osteoporosis and implication for RANKL aptamer therapy","volume":"8","author":"Zhang","year":"2020","journal-title":"Front Cell Dev Biol."},{"issue":"1","key":"2024012714033572800_jbmr4480-bib-0078","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s11914-006-0012-7","article-title":"Inhibition of RANKL as a treatment for osteoporosis: preclinical and early clinical studies","volume":"4","author":"McClung","year":"2006","journal-title":"Curr Osteoporos Rep."},{"key":"2024012714033572800_jbmr4480-bib-0079","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4137\/CMO.S8511","article-title":"Treatment-induced bone loss and fractures in cancer patients undergoing hormone ablation therapy: efficacy and safety of denosumab","volume":"6","author":"Lipton","year":"2012","journal-title":"Clin Med Insights Oncol."},{"issue":"24","key":"2024012714033572800_jbmr4480-bib-0080","doi-asserted-by":"crossref","first-page":"3482","DOI":"10.1101\/gad.11.24.3482","article-title":"Requirement for NF-kappaB in osteoclast and B-cell development","volume":"11","author":"Franzoso","year":"1997","journal-title":"Genes Dev"},{"issue":"9","key":"2024012714033572800_jbmr4480-bib-0081","doi-asserted-by":"crossref","first-page":"e72162","DOI":"10.1371\/journal.pone.0072162","article-title":"Type-specific cell line models for type-specific ovarian cancer research","volume":"8","author":"Anglesio","year":"2013","journal-title":"PLoS One."},{"issue":"8","key":"2024012714033572800_jbmr4480-bib-0082","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia."}],"container-title":["Journal of Bone and Mineral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jbmr.4480","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/jbmr.4480","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/3\/381\/55459384\/jbmr4480.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jbmr\/article-pdf\/37\/3\/381\/55459384\/jbmr4480.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T11:08:18Z","timestamp":1710328098000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jbmr\/article\/37\/3\/381-396\/7516809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,1]]},"references-count":82,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2021,12,13]]},"published-print":{"date-parts":[[2020,12,1]]}},"URL":"https:\/\/doi.org\/10.1002\/jbmr.4480","relation":{"has-review":[{"id-type":"doi","id":"10.1002\/JBMR.4480\/v2\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v2\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v2\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v2\/response1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v1\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v3\/decision1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v1\/review2","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v1\/review1","asserted-by":"object"},{"id-type":"doi","id":"10.1002\/JBMR.4480\/v3\/response1","asserted-by":"object"}]},"ISSN":["0884-0431","1523-4681"],"issn-type":[{"value":"0884-0431","type":"print"},{"value":"1523-4681","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2020,12,1]]},"published":{"date-parts":[[2020,12,1]]},"assertion":[{"value":"2021-08-23","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-11-20","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-13","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}